In the 20% of non-rectal cancer patients who still needed surgery post-therapy, researchers saw that the immunotherapy often shrunk the tumor and even lowered the stage classifications of some of ...

Christopher Sadowski “Using the standard-of-care treatment of surgery, radiation, and chemotherapy to treat rectal cancer is effective,” Cercek said. “But the treatments can leave people ...

I felt like I won the lottery!” Dr. Cerek reported that “20% of non-rectal cancer patients” who still had to undergo surgery “saw lower rates of cancer recurrence." She said this suggests ...

found that the immunotherapy treatment worked against not only advanced rectal cancer but other cancer types too, allowing patients to avoid surgery and other types of more invasive treatment to ...

So no surgery, no chemo, no radiation. Just immunotherapy," Cercek said. The best results were seen in patients with rectal cancer, all 49 of whom "experienced a complete clinical response ...

“Our results suggest that trying to save the anal sphincter in patients with distal rectal cancer whose tumors do not respond to neoadjuvant therapy may compromise recurrence-free survival.” Sphincter ...

Among patients with mismatch repair–deficient (dMMR), locally advanced rectal cancer, neoadjuvant checkpoint blockade eliminated the need for surgery in a high proportion of patients.

Patients with secondary rectal ... cancer had 6.2-fold shorter disease-free survival and 12.7-fold shorter distant recurrence-free survival. In matched analyses, only those undergoing surgery ...

At 35, Katie Dutton is already a rectal cancer survivor ... In May 2024, Dutton underwent surgery to remove all traces of the mass and most of her rectum. Rashidi then connected the healthy ...